After hours: March 14 at 7:59:07 PM EDT Loading Chart for MRNA ...

CureVac and partner GSK are, meanwhile, also developing an mRNA-based flu vaccine, but are a little further back in development, as their shot is in phase 1 testing.

GSK has upgraded its longstanding alliance with CureVac on mRNA-based vaccines for respiratory infections, paying €400 million ($429 million) upfront for global rights to its influenza and COVID ...

PepNL forms a mini-hairpin to block translation termination and stop codon readthrough counters this stalling. Ribosome ubiquitination regulates HAC1 mRNA processing during the unfolded protein ...

X-linked severe combined immunodeficiency disease (X-SCID) is a rare genetic disorder characterized by profound defects in ...

Scientists dive into the genomes of whales, elephants, and other animal giants looking for new weapons in the fight against ...

X-linked severe combined immunodeficiency disease (X-SCID) is a rare genetic disorder characterized by profound defects in T-cell, B-cell, and natural ...